Clinical and cost ineffectiveness of preoperative screening for methicillin-resistant Staphylococcus aureus and intranasal mupirocin in preventing methicillin-resistant S aureus infections in cardiothoracic surgery

American Journal of Infection Control

Volumn 39, Issue 3, 2011, Pages 243-246

  Cunha, Burke A ^a,b   Thekkel, Valsamma ^a   Schoch, Paul ^a   Cosgrove, Linda ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

cardiothoracic surgery; intransal; MRSA colonization; MRSA wound infections; prevention

Indexed keywords

BACITRACIN; CEFAZOLIN; PSEUDOMONIC ACID; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; GRAFT INFECTION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEDIASTINITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PATIENT COMPLIANCE; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; SHORT SURVEY; SURGICAL PATIENT;

EID: 79953661613     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.07.008     Document Type: Article

References (12)

1. Cunha BA. Clinical manifestations and antimicrobial therapy of methicillin-resistant Staphylococcus aureus (MRSA). Clin Microbiol Infect 3005;11:33-42.
2. Lee BY, Tsui BY, Bailey RR, Smith KJ, Muder RR, Lewis GJ, et al. Should vascular surgery patients be screened preopatively for methicillin-resistant Staph aureus? Infect Control Hosp Epidemiol 2009;30:1158-65.
3. Taylor MD, Napolitano LM. Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalence. Surg Infect 2004;5:180-7. (Pubitemid 40011979)
4. Murphy GJ, Pararajasingam R, Nasim A, Dennis MJ, Sayers RD. Methicillin-resistant Staphylococcus aureus infection in vascular surgical patients. Ann R Coll Surg Engl 2001;83:158-63. (Pubitemid 32509714)
5. Morange-Saussier V, Giraudeau B, van der Mee N, Lermusiaux P, Quentin R. Nasal carriage of methicillin-resistant Staphylococcus aureus in vascular surgery. Ann Vasc Surg 2006;20:767-72. (Pubitemid 46020504)
6. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299:1149-57. (Pubitemid 351398429)
7. Rymzhanova R, Thouverez M, Talon D, Bertrand X. Usefulness of weekly methicillin-resistant Staphylococcus aureus screening. Infect Control Hosp Epidemiol 2009;30:1113-5.
8. Trautmann M, Pollitt A, Loh U, Synowzik I, Reiter W, Stecher J, et al. Implementation of an intensified infection control program to reduce MRSA transmissions in a German tertiary care hospital. Am J Infect Control 2007;35:643-9. (Pubitemid 350184162)
9. Nasim A, Thompson MM, Naylor AR, Bell PR, London NJ. The impact of MRSA on vascular surgery. Eur J Vasc Endovasc Surg 2001;22:211-4. (Pubitemid 32780784)
10. Graves N, Halton K, Lairson D. Economics and preventing hospital-acquired infection: broadening the perspective. Infect Control Hosp Epidemiol 2007;28:178-84. (Pubitemid 46374158)
11. Coates T, Bax R, Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother 2009;64:9-15.
12. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin Infect Dis 2009;49:935-41.